![Synthesis and evaluation of antitumor activity of new 4-substituted thieno[3,2-d]pyrimidine and thienotriazolopyrimidine derivatives Cover](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/6470764c71e4585e08a9dafe/cover-image.jpg)
References
- 1. P. Mukherjee, H. Sevrioukova, I. Li, G. Chreifi, P. Martásek, L. J. Roman, T. L. Poulos and R. B. Silverman, Novel 2,4-disubstituted pyrimidines as potent, selective, and cell-permeable inhibitors of neuronal nitric oxide synthase, J. Med. Chem. 58 (2015) 1067-1088; https://doi.org/10.1021/jm501719e
- 2. H. N. Hafez, H. A. R. Hussein and A. B. A. El-Gazzar, Synthesis of substituted thieno [2,3-d]pyrimidine-2,4-dithiones and their S-glycoside analogues as potential antiviral and antibacterial agents, Eur. J. Med. Chem. 45 (2010) 4026-4034; https://doi.org/10.1016/j.ejmech.2010.05.060
- 3. H. N. Hafez and A. B. A. El-Gazzar, Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-d] pyrimidines as new bioactive and pharmacological activities, Bioorg. Med. Chem. Lett. 18 (2008) 5222-5227; https://doi.org/10.1016/j.bmcl.2008.08.071
- 4. H. M. Aly, N. M. Saleh and H. A. Elhady, Design and synthesis of some new thiophene, thienopyrimidine and thienothiadiazine derivatives of antipyrine as potential antimicrobial agents, Eur. J. Med. Chem. 46 (2011) 4566-4572; doi: 10.1016/j.ejmech.2011.07.035
- 5. H. N. Hafez, A. B. A. El-Gazzar and M. E. A. Zaki, Simple approach to thieno[3,2-d]-pyrimidines as new scaffolds of antimicrobial activities, Acta Pharm. 66 (2016) 331-351; https://doi.org/10.1515/acph-2016-0029
- 6. W. F. Zhu, X. Zhai, S Li, Y. Cao, P. Gong and Y. J. Liu, Synthesis and cytotoxic activity of novel 2,6-disubstituted-4-morpholino-thieno[3,2-d]pyrimidines as potent anti-tumor agents, Chin. Chem. Lett. 23 (2012) 703-706; https://doi.org/10.1016/j.cclet.2012.04.012
- 7. Z. Liu, S. Wu, Y. Wang, R. Li, J. Wang, L. Wang, Y. Zhao and P. Gong, Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents, Eur. J. Med. Chem. 87 (2014) 782-793; https://doi.org/10.1016/j.ejmech.2014.10.022
- 8. C. R. Ross, K. W. Temburnikar, G. M. Wilson and K. L. Seley-Radtke, Mitotic arrest of breast cancer MDA-MB-231 cells by halogenated thieno[3,2-d]pyrimidines, Bioorg. Med. Chem. Lett. 25 (2015) 1715-1717; https://doi.org/10.1016/j.bmcl.2015.02.071
- 9. S. N. Sirakanyan, E. K. Akopyan, R. G. Paronikyan, A. G. Akopyan and A. A. Ovakimyan, Synthesis and anticonvulsant activity of 7(8)-amino derivatives of condensed thieno[3,2-d]pyrimidines, Pharm. Chem. J. 50 (2016) 296-300; https://doi.org/10.1007/s11094-016-1439-5
- 10. H. N. Hafez, H. A. R. Hussein and A. B. A. El-Gazzar, Synthesis of substituted thieno[2,3-d]pyrimidine- 2,4-dithiones and their S-glycoside analogues as potential antiviral and antibacterial agents, Eur. J. Med. Chem. 45 (2010) 4026-4034; https://doi.org/10.1016/j.ejmech.2010.05.060
- 11. S. Kukolja, S. E. Draheim, B. J. Graves, D. C. Hunden, J. L. Pfeil, R. D. G. Cooper, J. L. Ot and F. T. Couter, Orally absorbable cephalosporin antibiotics. 2. Structure-activity studies of bicyclic glycine derivatives of 7-aminodeacetoxycephalosporanic acid, J. Med. Chem. 28 (1985) 1896-1903; https://doi.org/10.1021/jm00150a023
- 12. J. D. Prugh, G. D. Hartman, P. J. Mallorga, B. M. McKeever, S. R. Michelson, M. A. Murcko, H. Schwam, R. L. Smith, J. M. Sondey, J. P. Springer and M. F. Surgrue, New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene- 2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides, J. Med. Chem. 34 (1991) 1805-1818; https://doi.org/10.1021/jm00110a008
- 13. M. S. Egbertson, J. J. Cook, B. Bednar, J. D. Prugh, R. A. Bednar, S. L. Gaul, R. J. Gould, G. D. Hartman, C. F. Homnick, M. A. Holahan, L. A. Libby, J. J. Lynch Jr., R. J. Lynch, G. R. Sitko, M. T. Stranieri and L. M. Vassallo, Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained -thienothiophene α-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation, J. Med. Chem. 42 (1999) 2409-2421; https://doi.org/10.1021/jm980722p
- 14. R. S. Tamboli, R. D. Amrutkar, K. S. Jain and M. K. Kathiravan, Synthesis and in vivo a n t i h y - perlipidemic potential of novel substituted thieno[3,2-d]pyrimidines, Lett. Drug Des. Discov. 10 (2013) 906-915; https://doi.org/10.2174/15701808113109990019
- 15. Y. Endo, K. Kawai, T. Asano, S. Amano, Y. Asanuma, K. Sawada, Y. Onodera, N. Ueo, N. Takahashi, Y. Sonoda, N. Kamei and T. Irie, 2-(Isopropylamino)-thieno[3,2-d]-pyrimidin-4(3H)-one derivatives as selective phosphodiesterase 7 inhibitors with potent in vivo efficacy, Bioorg. Med. Chem. Lett. 25 (2015) 1910-1914; https://doi.org/10.1016/j.bmcl.2015.03.031
- 16. J. Kim, J. Kwon, D. Lee, S. Jo, D. S. Park, J. Choi, E. Park, J. Y. Hwang, Y. Ko, I. Choi, M. K. Ju, J. Ahn, J. Kim, S. J. Han, T. H. Kim, J. Cechetto, J. Nam, S. Ahn, P. Sommer, M. Liuzzi and J. Lee, Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors, Bioorg. Med. Chem Lett. 24 (2014) 5473-5477; https://doi.org/10.1016/j.bmcl.2014.10.007
- 17. M. Barone, G. Pannuzzo, A. Santagati, A. Catalfo, G. De Guidi and V. Cardile, Molecular docking and fluorescence characterization of benzothieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives, a novel class of selective cyclooxygenase-2 inhibitors, Molecules 19 (2014) 6106-6122; https://doi.org/10.3390/molecules19056106
- 18. Y. Ni, A. Gopalsamy, D. Cole, Y. Hu, R. Denny, M. Ipek, J. Liu, J. Lee, J. P. Hall, M. Luong, J. B. Telliez and L. L. Lin, Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors, Bioorg. Med. Chem. Lett. 21 (2011) 5952-5956; https://doi.org/10.1016/j.bmcl.2011.07.069
- 19. T. P. Heffron, M. Berry, G. Castanedo, C. Chang, I. Chuckowree, J. Dotson, A. Folkes, J. Gunzner, J. D. Lesnick, C. Lewis, S. Mathieu, J. Nonomiya, A. Olivero, J. Pang, D. Peterson, L. Salphati, D. Sampath, S. Sideris, D. P. Sutherlin, V. Tsui, N. C. Wan, S. Wang, S. Wong and B. Y. Zhu, Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor, Bioorg. Med. Chem. Lett. 20 (2010) 2408-2411; https://doi.org/10.1016/j.bmcl. 2010.03.046
- 20. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anti-cancer drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; https://doi.org/10.1093/jnci/82.13.1107
- 21. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paul, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo and J. M. Boyd, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst. 83 (1991) 757-766; https://doi.org/10.1093/jnci /83.11.757
- 22. A. S. Shestakov, M. A. Prezent, V. G. Kartsev and K. S. Shikhaliev, Synthesis of thieno[3,2-d]pyrimidin-4-ones and alkylation thereof, Eur. Chem. Bull. 7 (2014) 713-718; https://doi.org/10.17628/ECB.2014.3.713